Compensation award — excluded from discretionary-purchase analysis.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director sold ~$320K of HALO shares in the open market
Traded Sep 16, 2026 · Filed Sep 17, 2026
- ~$320K
- Reported value · 3,000 sh @ $106.83
- 72K
- Holds after · shares reported
- −0.1%
- stock since the trade · S&P 500 +2.8%, $108.44 → $108.31 on Oct 5
Why it stands out
A board member of Halozyme sold $320K of Halozyme shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Sep 16, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Sep 17, 2026
Director$100K–$500KPre-arranged plan referenced
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$320,484
Shares × reported transaction price
- Timing vs results
41 days after results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results